![](/img/cover-not-exists.png)
Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL
Voelkel-Johnson, Christina, King, Deanne Lea, Norris, James ScottVolume:
9
Year:
2002
Language:
english
Pages:
9
DOI:
10.1038/sj.cgt.7700420
File:
PDF, 1013 KB
english, 2002